CAPRICOR THERAPEUTICS, INC. (CAPR) Net income 2016–2025
CAPRICOR THERAPEUTICS, INC. (CAPR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$105.0MFY2025 · since FY2016: -$18.8M → -$105.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$105.0M | -159.6% |
| FY2024 | -$40.5M | -81.6% |
| FY2023 | -$22.3M | +23.2% |
| FY2022 | -$29.0M | -44.9% |
| FY2021 | -$20.0M | -46.6% |
| FY2020 | -$13.7M | -78.7% |
| FY2019 | -$7.6M | +49.7% |
| FY2018 | -$15.2M | -724.8% |
| FY2017 | $2.4M | +112.9% |
| FY2016 | -$18.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CAPR financial trends
CAPR RevenueCAPR Net marginCAPR Gross profitCAPR Gross marginCAPR Operating incomeCAPR Operating marginCAPR Operating cash flowCAPR Free cash flowCAPR Capital expendituresCAPR Return on equityCAPR Stock buybacksCAPR Dividends paidCAPR Total assetsCAPR Total liabilitiesCAPR Shareholders’ equityCAPR overview →